Señales en vivo de AGE | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 mar 2024 @ 15:59):

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States...

Stats
Volumen de hoy	3 681.00
Volumen promedio	3 980.00
Capitalización de mercado	27.76M
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-08	Mintz Steven	Sell	0	Common Stock, $0.0001 par value
2024-01-08	Mintz Steven	Sell	63 756	Option to Purchase Common Stock
2023-08-09	Renondin Jean-christophe	Sell	25 821	Option to Purchase Common Stock
2023-04-25	Juvenescence Ltd	Buy	756 429	Warrant to Purchase Common Stock
2023-03-14	Juvenescence Ltd	Sell	16 447 500	Common Stock

INSIDER POWER
-63.36
Last 97 transactions
Buy: 22 648 571 \| Sell: 17 037 050

AgeX Therapeutics Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AgeX Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$142 000
Beneficio Bruto:	$-29 000.00 (-20.42 %)
EPS:	$-13.72

FY	2023
Ingresos:	$142 000
Beneficio Bruto:	$-29 000.00 (-20.42 %)
EPS:	$-13.72

FY	2022
Ingresos:	$34 000.00
Beneficio Bruto:	$21 000.00 (61.76 %)
EPS:	$-9.89

FY	2021
Ingresos:	$144 000
Beneficio Bruto:	$125 000 (86.81 %)
EPS:	$-0.230

Financial Reports:

No articles found.

AgeX Therapeutics Inc

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.